ZL-1201
- Generic Name
- ZL-1201
A Trial of ZL-1201 in Subjects With Advanced Cancer
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT04257617
- Locations
- 🇺🇸
US2002, New York, New York, United States
🇺🇸US2001, Rochester, Minnesota, United States
🇨🇳CN1003, Chongqing, Chongqing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath